bf/NASDAQ:OCGN_icon.jpeg

NASDAQ:OCGN

Ocugen, Inc.

  • Stock

0.74

−1.22%

−0.29

USD last updated 13/08 01:59:42

Last Close

1.03

12/08 22:33

Market Cap

465.81M

Beta: 3.71

Volume Today

2.59M

Avg: 6.32M

PE Ratio

−1.82

PFCF: −1.70

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -4-2242019-05-152021-05-072023-05-052024-02-272024-11-08

    Revenue (Estimate*)

    20M40M60M80M2019-05-152021-05-072023-05-052024-02-272024-11-08

    *Estimate based on analyst consensus